Two Sigma Securities’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.1K | Sell |
10,436
-2,729
| -21% | -$3.17K | ﹤0.01% | 1288 |
|
2025
Q1 | $12.2K | Buy |
+13,165
| New | +$12.2K | ﹤0.01% | 1185 |
|
2024
Q3 | – | Sell |
-14,359
| Closed | -$23.1K | – | 2257 |
|
2024
Q2 | $23.1K | Buy |
+14,359
| New | +$23.1K | ﹤0.01% | 1235 |
|
2022
Q3 | – | Sell |
-10,368
| Closed | -$103K | – | 1927 |
|
2022
Q2 | $103K | Buy |
10,368
+10,014
| +2,829% | +$99.5K | ﹤0.01% | 800 |
|
2022
Q1 | $7K | Buy |
+354
| New | +$7K | ﹤0.01% | 1060 |
|
2021
Q4 | – | Sell |
-1,321
| Closed | -$49K | – | 1417 |
|
2021
Q3 | $49K | Buy |
+1,321
| New | +$49K | ﹤0.01% | 707 |
|
2021
Q2 | – | Sell |
-1,819
| Closed | -$122K | – | 1060 |
|
2021
Q1 | $122K | Buy |
1,819
+702
| +63% | +$47.1K | 0.01% | 456 |
|
2020
Q4 | $68K | Buy |
+1,117
| New | +$68K | ﹤0.01% | 560 |
|
2020
Q3 | – | Sell |
-1,055
| Closed | -$66K | – | 958 |
|
2020
Q2 | $66K | Buy |
1,055
+204
| +24% | +$12.8K | ﹤0.01% | 468 |
|
2020
Q1 | $45K | Sell |
851
-1,157
| -58% | -$61.2K | ﹤0.01% | 515 |
|
2019
Q4 | $243K | Buy |
2,008
+1,606
| +400% | +$194K | ﹤0.01% | 497 |
|
2019
Q3 | $73K | Sell |
402
-2,136
| -84% | -$388K | ﹤0.01% | 639 |
|
2019
Q2 | $330K | Buy |
+2,538
| New | +$330K | ﹤0.01% | 382 |
|
2018
Q2 | – | Sell |
-250
| Closed | -$61K | – | 1508 |
|
2018
Q1 | $61K | Buy |
+250
| New | +$61K | ﹤0.01% | 984 |
|